NGM Biopharmaceuticals names new board member

NGM Biopharmaceuticals, a US-based drug discovery company, has appointed Arthur Levinson to its board of directors.

Dr Levinson is currently the chairman of Genentech's board of directors, an advisor to Genentech's research and early development center and a member of Roche's scientific resource board.

In addition, Dr Levinson will be nominated to the board of directors of Roche Holding in March 2010.

David Goeddel, chairman and CEO of NGM Biopharmaceuticals, said: "Art's accomplishments and leadership during his 30 years at Genentech are legendary. His scientific and business acumen will be invaluable in shaping NGM's continued progress."

http://www.datamonitor.com
Republication or redistribution, including by framing or similar means,
is expressly prohibited without prior written consent. Datamonitor shall 
not be liable for errors or delays in the content, or for any actions 
taken in reliance thereon

Related terms: advisor, art, biopharmaceuticals, business, ceo, research, science